and importantly grouped together in one paper would be useful Participant recruitment: There doesn't seem to be enough information on recruitment -how were these participants identified? Via comm pharms? Via other methods? Who approached them? You also state that only data from consumers, carers and pharmacists will be included. As opposed to data from who else? What were the inclusion criteria for the pharmacists and carers? You state that a diverse, purposive sample was chosen? How did you go about doing this? What characteristics of your sample were you particularly interested in or did you go for maximum variation? At this point in the review, I had a look at references 15 and 33 to ascertain the method and found that this paper covers some similar ground to the other two papers in terms of the results it is reporting. There are many points in this paper that are essentially repeated from the other two papers e.g. primary use of pharmacy being for med supply, pharmacists role in information provision and how pharmacists interact with their patients.
I do, however, think there is some new information in this paper but all of the previously reported data needs to be stripped out. Perhaps this can be resubmitted as a short report -that conveys the survey data more specifically -which is actually quite useful and not reported elsewhere. The notion of the difference between pharmacists' perceptions and that of patients and carers is an important one and should potentially be explored in a revised (shorter) paper.
I would be happy to review a shorter, resubmitted manuscript.
REVIEWER

Kreshnik Hoti
Curtin University, Australia REVIEW RETURNED 06-Oct-2014
GENERAL COMMENTS
The conclusion needs some clarification. I am assuming authors concluded that people with chronic conditions sought services which improved their medication accesses and information but that were also patient centred. The later bit is not clear in the current version of the conclusion More details in regards to the qualitative approach and thematic analysis would be useful. For example, was the person conducting the interviews part of the research team? Was there an independent person checking sub-themes and coding with the view of bias minimisation? If so, this could be discussed in the limitation section.
Further details in terms of the 0-100 scale would be useful i.e. were there any specific reasons for choosing this particular scale as opposed to others? How was this data analysed (currently only thematic analysis clarified). Please provide clarification to ethical requirements such as participant information and consent in the methodology section. Authors have stated: "Community pharmacists were asked the same questions as consumer participants, except they were asked to consider the services that their consumers would like from pharmacy or pharmacists". Would be worthwhile re-submitting as a short report. A well written paper and the authors should be congratulated on some excellent work -however, I feel that this report is too long and not sufficiently different from the other two reports. Focussing solely on the survey results may be more appropriate and I would be happy to review a shorter paper. Apologies.
Response:
We have shortened the manuscript, which now focuses solely on the survey data. Response: This has been amended.
2. L28: terminology should remain consistent -in depth interviews versus semi-structured as stated earlier.
Response: We have ensured that the term 'semi-structured interviews' is used throughout the manuscript.
Intro. 3. Overall: A good introduction with some sensible points and reads quite well. It also sets the scene well for the paper. However, the structure is a bit out and could be improved (and shortened) to convey the message in a more concise and clearer way. All of the information is there to support the argument but some refinement is needed to make sure this gets across to the reader in a clearer fashion.
Response:
We agree with the reviewer's comments and have subsequently revised, and shortened, the introduction.
4. Quality Use of Medicines is capitalised and appears to be a name for a programme -this needs a reference if it is a specific programme and should be explained for an international audience. If it is not a programme and just a generic statement then it doesn't need to be capitalised.
Method. 8. 1st para: Why were only the interviews and survey used and not the discussion groups? Some justification of why these two were used and importantly grouped together in one paper would be useful. 10. At this point in the review, I had a look at references 15 and 33 to ascertain the method and found that this paper covers some similar ground to the other two papers in terms of the results it is reporting. There are many points in this paper that are essentially repeated from the other two papers e.g. primary use of pharmacy being for med supply, pharmacists role in information provision and how pharmacists interact with their patients.
Response: The authors specifically selected the interview and survey data as this included information which addressed the research question, i.e. to recognise the purpose/s for which
Response: The authors attempted to provide different data to that of the above papers, however, we agree with the reviewer that there were similarities with respect to the themes medication supply and advice and information. Subsequently, we have removed the qualitative data from this manuscript, and triangulated the results in the discussion section.
11. I do, however, think there is some new information in this paper but all of the previously reported data needs to be stripped out. Perhaps this can be resubmitted as a short report -that conveys the survey data more specifically -which is actually quite useful and not reported elsewhere. The notion of the difference between pharmacists' perceptions and that of patients and carers is an important one and should potentially be explored in a revised (shorter) paper.
Response: As discussed above, we have now shortened the paper to focus on the survey data and a comparison between the perceptions of consumers/carers and pharmacists.
Reviewer: 2
1. The conclusion needs some clarification. I am assuming authors concluded that people with chronic conditions sought services which improved their medication accesses and information but that were also patient centred. The later bit is not clear in the current version of the conclusion
Response:
We have made amendments to the conclusion so that it is clearer (Conclusion, paragraph 1, page 16): Overall, pharmacists had a reasonable understanding of what people with chronic conditions and carers would rate as important in terms of pharmacy services. Greater value was placed on how pharmacy services are delivered, i.e. in a patient-centred manner, particularly when providing medication information; consumers and carers placed great importance on personalised advice. Services were sought that improved consumer and carer access to medication, such as ongoing medication supply under a healthcare plan or pharmacist access to their medical or dispensing records. Further support is needed for pharmacists to integrate this type of care in their every-day practice, as well as to tailor service provision for specific groups such as carers.
2. More details in regards to the qualitative approach and thematic analysis would be useful. For example, was the person conducting the interviews part of the research team? Was there an independent person checking sub-themes and coding with the view of bias minimisation? If so, this could be discussed in the limitation section.
Response: This is no longer an issue with the revised manuscript as the qualitative data has been removed (see Reviewer 1 comments).
3. Further details in terms of the 0-100 scale would be useful i.e. were there any specific reasons for choosing this particular scale as opposed to others? How was this data analysed (currently only thematic analysis clarified).
Response: We have added further details about the development of the survey to the manuscript, including the reason/s for choosing the 0-100 scale (Method, paragraph 3, page 7):
The survey was informed by previous project findings, including the semi-structured interviews 1, 4 and nominal groups. 3 The survey was comprehensive as it addressed several aims of the overall project. To address the aims of this study, the survey asked consumers to indicate current service use, i.e. by ticking all the services that applied, as well as rate service importance on a visual analogue scale of 0-100, i.e. 100 = the pharmacy service has a very high importance for me and 0 = this pharmacy service is not important to me. The visual analogue scale was selected after discussion between research project members, as there were no validated scales for this measurement, and we wished to capture subtle variations in opinions which are not possible with a more truncated scale, i.e. 0-10. As previous stages of the project have identified that pharmacies are commonly utilised for medication access, 4, 5 survey questions focused beyond this service.
4. Please provide clarification to ethical requirements such as participant information and consent in the methodology section.
Response: Further information on participant information and consent processes is included (Method, paragraph 5, page 8):
Study information and surveys were posted or emailed to potential participants, who were subsequently contacted to confirm a date and time for a telephone or face-toface interview. Both verbal and written consent were obtained prior to data collection. There was also the risk of investigator-bias caused by utilising a mixture of face-to-face and telephone data collection methods. However, this is also recognised as a strength in terms of data triangulation, and ensured that groups that might be considered difficult to reach, including Aboriginal and Torres Strait Islander peoples and culturally and linguistically diverse participants, had the opportunity to participate.
8. Authors have stated that consumers were individually rated using the 0-100 scale. I could not find where these results were reported? If this was intentional, best to clarify that in the methodology.
Response: Participants were asked to rate, individually, the importance of pharmacy services or care to them, with the results provided in Table 3 (i.e. mean and IQR). We have re-written this information to make it clearer for the reader (Method, paragraph 3, page 7): To address the aims of this study, the survey asked consumers to indicate current service use, i.e. by ticking all the services that applied, as well as rate service importance on a visual analogue scale of 0-100, i.e. 100 = the pharmacy service has a very high importance for me and 0 = this pharmacy service is not important to me. The importance of continued medication supply was also confirmed by two other studies undertaken within the larger project, 3, 6 and support for this role by Australian consumers
